<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39392692</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2563-6316</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>JMIRx med</Title><ISOAbbreviation>JMIRx Med</ISOAbbreviation></Journal><ArticleTitle>Identification of COVID-19-Associated Hepatitis in Children as an Emerging Complication in the Wake of SARS-CoV-2 Infections: Ambispective Observational Study.</ArticleTitle><Pagination><StartPage>e48629</StartPage><MedlinePgn>e48629</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e48629</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/48629</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Although the pediatric population has largely remained free of severe COVID-19 symptoms, in some cases, SARS-CoV-2 infection has been associated with complications such as multiple inflammatory syndrome in children (MIS-C). We identified another a unique form of hepatitis occurring subsequent to asymptomatic SARS-CoV-2 infection, designated by us as COVID-19-associated hepatitis in children (CAH-C), in a subset of children who presented with hepatitis.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Our study describes the clinical presentations, temporal association, and viral parameters of the CAH-C cases and compares them to those of MIS-C cases or other known forms of hepatitis in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In an ambispective (retrospective and follow-up) observational study, records from April to July 2021 were reviewed for all children aged ≤14 years who were previously healthy and presented with a sudden onset of hepatitis, elevated transaminases, and nonobstructive jaundice. After performing all routine tests, those lacking marked inflammatory responses and without evidence of (1) other known causes of acute hepatitis or previous underlying liver disease and (2) multisystem involvement were classified as having CAH-C. Their characteristics were compared to those of children with MIS-C or other known forms of hepatitis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among the 5539 children tested for SARS-CoV-2, a total of 475 (8.6%) tested positive and 47 (0.8%) presented with hepatitis. Among the 47 children with hepatitis, 37 (79%) had features of CAH-C: having symptoms of hepatitis only, without protracted illness (mean length of stay 5 d), and an uneventful recovery following supportive treatment. In contrast, the remaining 10 (21%) had features of MIS-C-associated hepatitis: multiple system involvement; protracted illness (mean length of stay 8 d); and requiring admission to critical care, with a mortality rate of 30% (3/10).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our data suggest that CAH-C might be one of the new clinical complications associated with the emergence of newer variants of concern of SARS-CoV-2, which often result in changing presentations. Our findings should facilitate its early identification and thorough workup and aid its differentiation from other emerging syndromes in children, which would help initiate appropriate measures, enable better resource prioritization, and thus limit adversities.</AbstractText><CopyrightInformation>© Sumit Kumar Rawat, Ajit Anand Asati, Nitu Mishra, Ashish Jain, Radha Kanta Ratho. Originally published in JMIRx Med (https://med.jmirx.org).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rawat</LastName><ForeName>Sumit Kumar</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0002-8222-5486</Identifier><AffiliationInfo><Affiliation>Bundelkhand Medical College and Hospital, Sagar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asati</LastName><ForeName>Ajit Anand</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0009-0004-6412-056X</Identifier><AffiliationInfo><Affiliation>Bundelkhand Medical College and Hospital, Sagar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Nitu</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9288-4306</Identifier><AffiliationInfo><Affiliation>Bundelkhand Medical College and Hospital, Sagar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Ashish</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0001-7874-0493</Identifier><AffiliationInfo><Affiliation>Bundelkhand Medical College and Hospital, Sagar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratho</LastName><ForeName>Radha Kanta</ForeName><Initials>RK</Initials><Identifier Source="ORCID">0000-0001-7205-9325</Identifier><AffiliationInfo><Affiliation>Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIRx Med</MedlineTA><NlmUniqueID>101776650</NlmUniqueID><ISSNLinking>2563-6316</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.1101/2021.07.23.21260716</RefSource></CommentsCorrections><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.2196/preprints.48629</RefSource></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">child</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">hepatic</Keyword><Keyword MajorTopicYN="N">hepatitis</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">inflammatory</Keyword><Keyword MajorTopicYN="N">jaundice</Keyword><Keyword MajorTopicYN="N">liver</Keyword><Keyword MajorTopicYN="N">observational</Keyword><Keyword MajorTopicYN="N">pediatric</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword><Keyword MajorTopicYN="N">retrospective</Keyword><Keyword MajorTopicYN="N">youth</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>18</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>18</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>12</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39392692</ArticleId><ArticleId IdType="pmc">PMC11488459</ArticleId><ArticleId IdType="doi">10.2196/48629</ArticleId><ArticleId IdType="pii">v5i1e48629</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021 Mar;19(3):141–154. doi: 10.1038/s41579-020-00459-7. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708–1720. doi: 10.1056/NEJMoa2002032. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021 Oct;5(10):708–718. doi: 10.1016/S2352-4642(21)00198-X. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020 May 23;395(10237):1607–1608. doi: 10.1016/S0140-6736(20)31094-1. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31094-1</ArticleId><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner RM, Whittaker E. Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet. 2020 Jun 6;395(10239):1741–1743. doi: 10.1016/S0140-6736(20)31129-6. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31129-6</ArticleId><ArticleId IdType="pmc">PMC7220168</ArticleId><ArticleId IdType="pubmed">32410759</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020 Jul 23;383(4):334–346. doi: 10.1056/NEJMoa2021680. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh PP, Rai SK, Chaubey G, Serosurveillance Consortium BHU Estimation of real COVID-19 cases in India during the first wave. IJID Reg. 2023 Mar;6:80–83. doi: 10.1016/j.ijregi.2023.01.008. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijregi.2023.01.008</ArticleId><ArticleId IdType="pmc">PMC9851738</ArticleId><ArticleId IdType="pubmed">36694810</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallapaty S. India’s massive COVID surge puzzles scientists. Nature. 2021 Apr 21;592(7856):667–668. doi: 10.1038/d41586-021-01059-y. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01059-y</ArticleId><ArticleId IdType="pubmed">33883710</ArticleId></ArticleIdList></Reference><Reference><Citation>Weekly epidemiological update on COVID-19 - 29 March 2022. World Health Organization. Mar 29, 2022.  [08-07-2024]. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---29-march-2022 URL. Accessed.</Citation></Reference><Reference><Citation>Gupta Dch S, Chopra Md N, Singh Md A, et al. Unusual clinical manifestations and outcome of multisystem inflammatory syndrome in children (MIS-C) in a tertiary care hospital of North India. J Trop Pediatr. 2021 Jan 29;67(1):fmaa127. doi: 10.1093/tropej/fmaa127. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmaa127</ArticleId><ArticleId IdType="pmc">PMC7928672</ArticleId><ArticleId IdType="pubmed">33513240</ArticleId></ArticleIdList></Reference><Reference><Citation>Narahari KK, Pothala R, Bathina SP, Deshmukh N, Kumar C. Cholestatic jaundice as a manifestation of multisystem inflammatory syndrome in children (MIS-C) Indian J Pediatr. 2021 Oct;88(10):1051. doi: 10.1007/s12098-021-03867-6. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-021-03867-6</ArticleId><ArticleId IdType="pmc">PMC8316099</ArticleId><ArticleId IdType="pubmed">34318407</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfred-Cato S, Bryant B, Leung J, et al. COVID-19–associated multisystem inflammatory syndrome in children — United States, March–July 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1074–1080. doi: 10.15585/mmwr.mm6932e2. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6932e2</ArticleId><ArticleId IdType="pmc">PMC7440126</ArticleId><ArticleId IdType="pubmed">32790663</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantor A, Miller J, Zachariah P, DaSilva B, Margolis K, Martinez M. Acute hepatitis is a prominent presentation of the multisystem inflammatory syndrome in children: a single-center report. Hepatology. 2020 Nov;72(5):1522–1527. doi: 10.1002/hep.31526. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.31526</ArticleId><ArticleId IdType="pmc">PMC7655704</ArticleId><ArticleId IdType="pubmed">32810894</ArticleId></ArticleIdList></Reference><Reference><Citation>Phipps MM, Barraza LH, LaSota ED, et al. Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large U.S. cohort. Hepatology. 2020 Sep;72(3):807–817. doi: 10.1002/hep.31404. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.31404</ArticleId><ArticleId IdType="pmc">PMC7300739</ArticleId><ArticleId IdType="pubmed">32473607</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber S, Hellmuth JC, Scherer C, Muenchhoff M, Mayerle J, Gerbes AL. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study. Gut. 2021 Oct;70(10):1925–1932. doi: 10.1136/gutjnl-2020-323800. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323800</ArticleId><ArticleId IdType="pmc">PMC7852072</ArticleId><ArticleId IdType="pubmed">33514597</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez A, Cantor A, Rudolph B, et al. Liver involvement in children with SARS-CoV-2 infection: two distinct clinical phenotypes caused by the same virus. Liver Int. 2021 Sep;41(9):2068–2075. doi: 10.1111/liv.14887. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.14887</ArticleId><ArticleId IdType="pmc">PMC8251417</ArticleId><ArticleId IdType="pubmed">33826804</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe acute hepatitis of unknown origin in children - multicountry. World Health Organization. Apr 23, 2022.  [08-07-2024]. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON376 URL. Accessed.</Citation></Reference><Reference><Citation>UK Health Security Agency  Investigation into acute hepatitis of unknown aetiology in children in England: technical briefing 4. GOV.UK. Jul 26, 2022.  [08-07-2024]. https://assets.publishing.service.gov.uk/media/62e160b0e90e07142da0176e/acute-hepatitis-technical-briefing-4.pdf URL. Accessed.</Citation></Reference><Reference><Citation>Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021 Jan;41(1):20–32. doi: 10.1111/liv.14730. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.14730</ArticleId><ArticleId IdType="pmc">PMC7753756</ArticleId><ArticleId IdType="pubmed">33190346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N. 45 Smart city command and control centres turn into COVID-19 war rooms. The Economic Times. Mar 31, 2020.  [08-07-2024]. https://economictimes.indiatimes.com/news/politics-and-nation/45-smart-city-command-andcontrol-centres-turn-into-covid-19-war-rooms/articleshow/74904329.cms URL. Accessed.</Citation></Reference><Reference><Citation>Department of Health Research  ICMR advises states to conduct sero-survey to measure coronavirus exposure in the population using IgG ELISA test. Indian Council of Medical Research. May 30, 2020.  [08-07-2024]. https://main.icmr.nic.in/sites/default/files/press_realease_files/ICMR_PR_IgG_Elisa_30052020.pdf URL. Accessed.</Citation></Reference><Reference><Citation>Health Alert Network (HAN)  Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) Centers for Disease Control and Prevention. May 14, 2020.  [08-07-2024]. https://emergency.cdc.gov/han/2020/han00432.asp URL. Accessed.</Citation></Reference><Reference><Citation>COVID-19 dashboard. Ministry of Health and Family Welfare, Government of India.  [23-07-2024]. https://covid19dashboard.mohfw.gov.in/ URL. Accessed.</Citation></Reference><Reference><Citation>Salamanna F, Maglio M, Landini MP, Fini M. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med (Lausanne) 2020 Dec 3;7:594495. doi: 10.3389/fmed.2020.594495. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.594495</ArticleId><ArticleId IdType="pmc">PMC7744810</ArticleId><ArticleId IdType="pubmed">33344479</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Niu Z, Jiang X, et al. SARS-CoV-2 targets by the pscRNA profiling of ACE2, TMPRSS2 and furin proteases. iScience. 2020 Nov 20;23(11):101744. doi: 10.1016/j.isci.2020.101744. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101744</ArticleId><ArticleId IdType="pmc">PMC7591870</ArticleId><ArticleId IdType="pubmed">33134888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Y, Zhao X, Wang Y, et al. Abnormal liver function tests were associated with adverse clinical outcomes: an observational cohort study of 2,912 patients with COVID-19. Front Med (Lausanne) 2021 Jun 9;8:639855. doi: 10.3389/fmed.2021.639855. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.639855</ArticleId><ArticleId IdType="pmc">PMC8219933</ArticleId><ArticleId IdType="pubmed">34179034</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreews M, Le Gouge K, Khaldi-Plassart S. Polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T cells is a hallmark of multisystem inflammatory syndrome in children. Sci Immunol. 2021 May 25;6(59):eabh1516. doi: 10.1126/sciimmunol.abh1516. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abh1516</ArticleId><ArticleId IdType="pmc">PMC8815705</ArticleId><ArticleId IdType="pubmed">34035116</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020 Nov 12;183(4):968–981.e7. doi: 10.1016/j.cell.2020.09.016. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg SP, Connors TJ, Zhu Y, et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol. 2021 Jan;22(1):25–31. doi: 10.1038/s41590-020-00826-9. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00826-9</ArticleId><ArticleId IdType="pmc">PMC8136619</ArticleId><ArticleId IdType="pubmed">33154590</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020 May 12;323(18):1824–1836. doi: 10.1001/jama.2020.6019. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6019</ArticleId><ArticleId IdType="pubmed">32282022</ArticleId></ArticleIdList></Reference><Reference><Citation>Maves RC, Dean K, Gadea N, Halsey ES, Graf PCF, Lescano AG. False-positive rapid plasma reagin testing in patients with acute Plasmodium vivax malaria: a case control study. Travel Med Infect Dis. 2014;12(3):268–273. doi: 10.1016/j.tmaid.2013.10.010. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2013.10.010</ArticleId><ArticleId IdType="pmc">PMC4041835</ArticleId><ArticleId IdType="pubmed">24201039</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>